COST

1,000.84

+1.21%↑

159.15

+0.33%↑

65.39

+0.03%↑

94.4

-0.36%↓

SYY

86.5

+2.25%↑

COST

1,000.84

+1.21%↑

159.15

+0.33%↑

65.39

+0.03%↑

94.4

-0.36%↓

SYY

86.5

+2.25%↑

COST

1,000.84

+1.21%↑

159.15

+0.33%↑

65.39

+0.03%↑

94.4

-0.36%↓

SYY

86.5

+2.25%↑

COST

1,000.84

+1.21%↑

159.15

+0.33%↑

65.39

+0.03%↑

94.4

-0.36%↓

SYY

86.5

+2.25%↑

COST

1,000.84

+1.21%↑

159.15

+0.33%↑

65.39

+0.03%↑

94.4

-0.36%↓

SYY

86.5

+2.25%↑

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

21.24 2.81

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.13

Max

21.36

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	24.067 29.995
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-17

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	14M 396M
Ankstesnė atidarymo kaina	18.43
Ankstesnė uždarymo kaina	21.24

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-08 23:57; UTC

Rinkos pokalbiai

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

2026-02-08 23:47; UTC

Rinkos pokalbiai

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

2026-02-08 23:43; UTC

Rinkos pokalbiai

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

2026-02-08 23:34; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-08 23:34; UTC

Rinkos pokalbiai

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

2026-02-08 23:26; UTC

Rinkos pokalbiai

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

2026-02-08 22:55; UTC

Uždarbis

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

2026-02-08 22:55; UTC

Uždarbis

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

2026-02-08 22:55; UTC

Uždarbis

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

2026-02-08 22:55; UTC

Uždarbis

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

2026-02-08 22:55; UTC

Uždarbis

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

2026-02-08 22:55; UTC

Uždarbis

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

2026-02-08 21:43; UTC

Rinkos pokalbiai

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

2026-02-08 21:16; UTC

Rinkos pokalbiai

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

2026-02-08 21:15; UTC

Rinkos pokalbiai

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

2026-02-07 09:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-07 09:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-07 05:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-07 02:46; UTC

Įsigijimai, susijungimai, perėmimai

Big Money, High Anxiety -- Barrons.com

2026-02-06 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-06 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-06 21:40; UTC

Įsigijimai, susijungimai, perėmimai

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

2026-02-06 21:22; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Accelerating in January -- Market Talk

2026-02-06 21:17; UTC

Uždarbis

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026-02-06 21:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-06 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

2026-02-06 21:13; UTC

Uždarbis

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

2026-02-06 21:13; UTC

Uždarbis

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

2026-02-06 21:04; UTC

Rinkos pokalbiai

Gold Closes Out Volatile Week on Higher Note -- Market Talk

2026-02-06 20:34; UTC

Uždarbis

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.